Ramsay Santé Set for Independence as Parent RHC Plans Full Divestment

PARIS, France – February 20, 2026 – European healthcare leader Ramsay Santé is poised to enter a new era of autonomy after its Australian majority shareholder, Ramsay Health Care (RHC), announced a proposal to distribute its entire 52.79% stake to its own shareholders. The move, expected to be completed by the end of 2026, would effectively uncouple the two entities, allowing Ramsay Santé to chart its own course as a fully independent, European-focused healthcare provider.

The proposal follows a strategic review initiated by RHC in November 2025 to assess its investment in its Paris-listed subsidiary. While the distribution is the primary path forward, RHC has noted that it remains open to considering alternative options, including potential discussions with interested third parties.

For Ramsay Santé, which operates 492 facilities across five European countries, the announcement marks a pivotal moment. The company has long operated with its own management team, balance sheet, and financing structure, but this formal separation will redefine its shareholder base and strategic freedom.

“The proposal announced today would open a new chapter for Ramsay Santé, following years of confidence from RHC as a key shareholder alongside Crédit Agricole Assurances,” said Pascal Roché, CEO of Ramsay Santé, in a statement. “Our group has solid resources and positions that allow us to approach this step with confidence and serenity.”

A Strategic Uncoupling Driven by Focus

The decision by Sydney-based Ramsay Health Care is widely seen as a strategic pivot to simplify its corporate structure and concentrate on its core Australian operations. For years, analysts and investors have pointed to the differing dynamics between RHC's domestic market and its European division. While RHC's Australian and UK businesses have shown solid performance, the European segment has faced significant headwinds.

Financial reports over the past two years have highlighted the challenges within Ramsay Santé, which has contended with persistent cost inflation, rising wage pressures, and regulatory constraints, particularly in the French market where price caps and staffing shortages have eroded margins. The European division's weaker results have at times offset gains elsewhere in the RHC group, leading some market observers to describe the European arm as an "albatross" for the Australian parent. The proposed demerger is therefore seen as a logical step to unlock value for both entities by allowing each to pursue a more focused strategy tailored to its unique market.

By distributing its shares, RHC allows its own investors to retain a direct economic interest in the European business through a separate holding, while RHC itself can focus capital and management attention on transforming its primary Australian hospital network.

Navigating a New Shareholder Landscape

The mechanics of the transaction will be executed through a 'scheme of arrangement' under Australian law, a process requiring approval from RHC's board, its shareholders, and relevant courts. RHC shareholders are set to receive a proportional number of shares in Ramsay Santé, effectively turning a single holding into two distinct investments. To facilitate this for Australian investors, RHC plans to help establish CHESS Depositary Interests (CDIs) that can be traded on the Australian Securities Exchange (ASX), mirroring the value of Ramsay Santé shares listed on Euronext Paris.

This distribution will dramatically reshape Ramsay Santé's ownership structure, significantly increasing its free float and diversifying its shareholder base. A key element of stability in this transition is the stated position of its other major shareholder, Crédit Agricole Assurances (CAA). Through its subsidiary Predica, CAA holds a 39.82% stake and has been a long-term partner since 2010.

In conjunction with the demerger, the shareholders' agreement between RHC and CAA, in place since 2014, will be terminated effective October 1, 2026. Despite this, CAA has firmly reiterated its commitment as a long-term shareholder and confirmed it does not intend to increase its stake or seek control of the company. This assurance provides a crucial anchor of stability, mitigating concerns about potential volatility as the company's shares become more widely held.

Financial Hurdles and a Clear Strategic Roadmap

While the path to independence is clear, it is not without complexity. The change in majority ownership is expected to trigger a 'change of control' clause within Ramsay Santé's primary credit agreement—a facility totaling €1.65 billion. This will require the company to enter into discussions with its main financial partners to secure necessary consents or contractual adjustments.

However, Ramsay Santé is approaching this hurdle from a position of strength, having demonstrated proactive financial management. The company successfully completed 'Amend & Extend' refinancing transactions in 2024 and 2025, pushing its debt maturities out to 2031 and creating a stable financial foundation. Furthermore, its innovative use of financing includes ESG-linked loans, underscoring a sophisticated approach to its capital structure that should instill confidence in its financial partners during the upcoming negotiations.

Looking ahead, Ramsay Santé's leadership has emphasized continuity and ambition. The group intends to aggressively pursue its existing strategic roadmap, which is built on investment in medical innovation, achieving operational excellence, and maintaining rigorous financial discipline. CEO Pascal Roché framed the move as an opportunity to build on the company's mission of improving health through constant innovation.

The indicative timeline for the transaction places the publication of the official demerger booklet in October 2026, with an RHC shareholder vote scheduled for November. Subject to all necessary approvals, the transaction is expected to be finalized in December 2026, officially launching Ramsay Santé on its independent journey.